Marker Therapeutics (MRKR) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.8
-0.57
-0.35
-0.12

Details

Expected EPS
N/A
Actual EPS
-0.34
Surprise EPS
-0.34
Surprise Percent
+∞%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.34 per share for Q3 2023.

0 Comments

Share your thoughts